Trust Point’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,411
Closed -$665K – 540
2026
Q2
$665K Sell
9,411
-3,927
-29% -$212K 0.06% 177
2026
Q1
$697K Sell
13,338
-87
-0.6% -$5.22K 0.06% 174
2025
Q4
$790K Buy
13,425
+271
+2% +$16.5K 0.06% 155
2025
Q3
$732K Buy
13,154
+1,104
+9% +$59.1K 0.06% 157
2025
Q2
$620K Sell
12,050
-3,208
-21% -$161K 0.06% 150
2025
Q1
$895K Sell
15,258
-780
-5% -$52.9K 0.08% 126
2024
Q4
$1.16M Buy
16,038
+7,333
+84% +$538K 0.08% 133
2024
Q3
$696K Buy
8,705
+326
+4% +$24.5K 0.05% 222
2024
Q2
$600K Buy
8,379
+237
+3% +$17.4K 0.05% 240
2024
Q1
$573K Buy
8,142
+55
+0.7% +$3.94K 0.05% 259
2023
Q4
$624K Buy
+8,087
New +$533K 0.05% 226

Other funds holding TECH

Trust Point's TECH Position: Q3 2026 in Review

Trust Point sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 9,411 shares — an estimated $665K sold.

Trust Point first reported a position in TECH in Q4 2023 and held it in 11 quarters. The position peaked at $1.16M in Q4 2024. 451 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Trust Point reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Trust Point sold 9,411 Bio-Techne shares in Q3 2026, an estimated $665K.
  • Trust Point first reported a position in Bio-Techne in Q4 2023 and held it in 11 quarters.
  • Trust Point's Bio-Techne position peaked at $1.16M in Q4 2024.
  • 451 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.